InvestorsHub Logo
Followers 33
Posts 5264
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Wednesday, 03/01/2023 2:49:19 PM

Wednesday, March 01, 2023 2:49:19 PM

Post# of 424170
KM is so full of BS read this excerpt from todays CC then read what's posted on the Eddingpharm pitchbook.

Regarding China, our partner Eddingpharm is in charge of the regulatory review process. In their latest update, Edding indicated they expect an approval by mid-year as a result of delays related to the shutdown of the regulatory process in China for a period of time due to COVID-19 restrictions. We are working very closely with Edding to ensure we have the latest update from our partner. As of today, we have not received any indication that there are any open questions or concerns regarding the regulatory filing for our product.


Eddingpharm Valuation & Funding
Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 03-Feb-2023 Cancelled Generating Revenue

6. Later Stage VC (Series E) 29-Jul-2019
Completed Generating Revenue
5. Later Stage VC (Series D1) 18-Jan-2019
Completed Generating Revenue
4. Later Stage VC (Series D) 08-Nov-2016
Completed Generating Revenue
3. Later Stage VC (Series C) 29-Feb-2016
Completed Generating Revenue
2. Later Stage VC (Series B) 05-Aug-2010 $24M $36M Completed Generating Revenue
1. Later Stage VC (Series A) 29-May-2008 $12M $12M Completed Generating Revenue
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News